Resuscitation Outcomes in the Netherlands Flashmob Questionnaire

NCT ID: NCT03807206

Last Updated: 2019-07-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1136 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-01-01

Study Completion Date

2019-02-07

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to gain insight in patients' experiences regarding do not resuscitate conversations and decisions. A multicentre flash mob investigation will be conducted in which data will be obtained over the course of two weeks using electronic questionnaires that patients will fill out. General demographic data and a brief quality of life assessment (EQ-5D) will be collected. Whether a DNR converstation has taken place will be noted, along with patients' experiences with this conversation. Lastly the patient will be asked about his/her expectations of survival after cardiopulmonary resuscitation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Rationale: In-hospital cardiac arrest, associated with a survival to discharge of 15.0%, results in a good neurologic discharge in 9.1% - 30.0% of patients. Therefore it is recommended to engage in advanced care planning with patients, to discuss do-not-resuscitate (DNR) directives. In current knowledge, there are no published data about the prevalence of these DNR orders and associated factors in hospitalized patients in the Netherlands. Also, the conversation about DNR are sometimes perceived as awkward or untimely by patients.

Objective: The primary goal is to estimate prevalence DNR order in Dutch hospitals. A secondary goal is to assess what geographical, patient and disease factors are associated with DNR status. Furthermore patient experience in the conversation leading to DNR-orders is of interest.

Study design: A cross-sectional point prevalence study, in 10 participating hospitals of the ROUTiNE project.

Study population: Patients who plan to be admitted for more than 24 hours to the participating hospitals, aged 18 or older, who are responsive and conscious.

Main study parameters/endpoints: The prevalence of DNR orders, expressed as number per 1000 beds.

Nature and extent of the burden and risks associated with participation, benefit and group relatedness: There is no risk. Only one ten-minute interview per participant. Therefore the benefit of this study (as described in the objectives) outweigh the potential risks.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiopulmonary Arrest DNR-orders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Flashmob 2019

Patients from the following hospitals will receive a questionnaire/structured intereview: Erasmus MC, Franciscus Gasthuis \& Vlietland, Ikazia, Haaglanden Medisch Centrum, Albert Schweitzer ziekenhuis, Jeroen Bosch ziekenhuis, Rijnstate ziekenhuis, Amphia ziekenhuis, Tergooi klinieken, Medisch Spectrum Twente, Reinier de Graaf gasthuis. Pending: Maasstad ziekenhuis

Questionnaire

Intervention Type BEHAVIORAL

Patient questionnaire

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Questionnaire

Patient questionnaire

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

structured interview

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients admitted to the participating hospitals with a planned admission \>24 hours at the moment this study takes place.

Exclusion Criteria

* • Refusal to participate

* \<18 years of age
* Admitted in outpatient clinic and day treatment centres (e.g. haemodialysis)
* Admitted \<24 hours, as defined by not sleeping overnight in hospital
* No reliable proxy in the following situations:

* Unable to answer questions (e.g. unconscious, cognitively impaired, delirious)
* Language barrier (with no interpreter or family member)
* The following hospital departments are excluded:

* Intensive care unit
* Coronary/acute cardiac care unit
* Obstetrics
* Paediatrics
* Stroke unit
* Dialysis (outpatient dialysis)
* Day-care wards/short-stay (i.e. \<1 day)
* Palliative care
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

European Society of Anaesthesiology

OTHER

Sponsor Role collaborator

Erasmus Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Marc Schluep

principal investigator/medical doctor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Robert Jan Stolker, MD PhD

Role: PRINCIPAL_INVESTIGATOR

Erasmus Medical Center

Monique van Dijk, MD PhD

Role: PRINCIPAL_INVESTIGATOR

Erasmus Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Jeroen Bosch ziekenhuis

's-Hertogenbosch, , Netherlands

Site Status

Rijnstate

Arnhem, , Netherlands

Site Status

Amphia

Breda, , Netherlands

Site Status

Reinier de Graaf gasthuis

Delft, , Netherlands

Site Status

Albert Schweitzer ziekenhuis

Dordrecht, , Netherlands

Site Status

Medisch Spectrum Twente

Enschede, , Netherlands

Site Status

Tergooi ziekenhuizen

Hilversum, , Netherlands

Site Status

Erasmus MC

Rotterdam, , Netherlands

Site Status

Franciscus Gasthuis & Vlietland

Rotterdam, , Netherlands

Site Status

Ikazia

Rotterdam, , Netherlands

Site Status

Maasstad

Rotterdam, , Netherlands

Site Status

Haaglanden Medisch Centrum

The Hague, , Netherlands

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Netherlands

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ROUTINE-F

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.